Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Study of Efficacy of Befizal® 200 mg for the Treatment of Leber Hereditary Optic Neuropathy

NCT04561466 is registered in ClinicalTrials.gov with Hôpital Necker-Enfants Malades as lead sponsor.

NCT NCT04561466
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04561466 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Study of Efficacy of Befizal® 200 mg for the Treatment of Leber Hereditary Optic Neuropathy
Lead sponsor
Hôpital Necker-Enfants Malades
Phase
Phase 2/3
Overall status
Completed
Start date
March 26, 2019
Completion date
March 10, 2023
Enrollment
14 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

efficacy, self, safety issues